GAD65 antibodies associate also with cerebellar ataxia (and less frequently with focal epilepsy) and of course with diabetes type 1; thus, these are often comorbidities in GAD-antibody positive SPSD patients, just as autoimmune thyroid disease or vitiligo. The gene discussed is GAD2; the disease is type 1 diabetes mellitus.